Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer

Author:

Dunsmore Jennifer1ORCID,Duncan Eilidh2ORCID,MacLennan Sara J.1ORCID,N'Dow James1ORCID,Cornford Philip3ORCID,Esperto Francesco4ORCID,Pavan Nicola5ORCID,Ribal María J.6ORCID,Roobol Monique J.7ORCID,Skolarus Ted A.89ORCID,MacLennan Steven1ORCID

Affiliation:

1. Academic Urology Unit University of Aberdeen Aberdeen UK

2. Health Service Research Unit University of Aberdeen Aberdeen UK

3. Liverpool University Hospitals Liverpool UK

4. Department of Urology Campus Biomedico University of Rome Rome Italy

5. Urology Section, Department of Surgical, Oncological and Stomatological Sciences University of Palermo Palermo Italy

6. Uro‐Oncology Unit, Hospital Clinic University of Barcelona Barcelona Spain

7. Department of Surgery, Urology Section Erasmus University Medical Center Rotterdam, Cancer Institute Rotterdam The Netherlands

8. VA Ann Arbor Healthcare System Ann Arbor Michigan USA

9. The University of Chicago Chicago Illinois USA

Abstract

AbstractObjectivesTo understand how best to further reduce the inappropriate use of pre‐surgical androgen deprivation therapy (ADT), we investigated the determinants (influences) of ADT prescribing in urologists in two European countries using an established behavioural science approach. Additionally, we sought to understand how resource limitations caused by COVID‐19 influenced this practice. Identification of key determinants, of undistributed and disrupted practice, will aid development of future strategies to reduce inappropriate ADT prescribing in current and future resource‐limited settings.Participants and MethodsWe conducted semi‐structured qualitative interviews with urologists practicing in Italy and the UK from February to July 2022. Interviews focussed on undisrupted (usual) practice and disrupted practice (changes made during COVID‐19 restrictions). Codes were generated inductively and were mapped to the 14 domains of the Theoretical Domains Framework. Relevant domains of influence were identified, and the similarities and differences between the UK and Italy were distinguished.ResultsWe identified 10 domains that were influential to ADT prescribing in the UK and eight in Italy. The role of guidance and evidence, the cancer care setting, the patients and the urologist's beliefs and experiences were identified as areas that were influential to ADT prescribing before surgery. Twenty‐one similarities and 22 differences between the UK and Italy, for usual and COVID‐19 practice, were identified across these 10 domains.ConclusionSimilarities and differences influencing ADT prescribing prior to surgery should be considered in behavioural strategy development and tailoring to reduce inappropriate ADT use. We gained an understanding of usual, undistributed care and resource‐limited or disrupted care due to COVID‐19 in two European countries. This gives an indication of how influences on ADT prescribing may change in future resource‐limited circumstances and where efforts can be focused now and in future.

Publisher

Wiley

Reference29 articles.

1. WHO.COVID‐19 has caused major disruptions and backlogs in health care new WHO study finds [Internet].2022[cited 2023 Sep 20]; Available from:https://www.who.int/europe/news/item/20-07-2022-covid-19-has-caused-major-disruptions-and-backlogs-in-health-care--new-who-study-finds

2. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

3. Global challenges to urology practice during the COVID-19 pandemic

4. British Association of Urological Surgeons.COVID‐19 strategy for the interim management of prostate cancer prepared by the BAUS section of oncology.2020.

5. Androgen deprivation monotherapy usage in non-metastatic prostate cancer: results from eight European countries

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3